Related Experiment Video
Updated: Dec 25, 2025

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Defining Topical Corticosteroids by Allergenicity and Cross-Reactivity for the Contact Allergen Management Program
Rachit Gupta1, Sara Hylwa, Matthew Zirwas
1Park Nicollet Contact Dermatitis Clinic, Minneapolis, MN, University of Minnesota Medical School, Minneapolis Park Nicollet Contact Dermatitis Clinic, Minneapolis, MN, CAMP Cross-Reactor Committee 2019-2020, Sara.Hylwa@gmail.com, Department of Dermatology, University of Minnesota, Minneapolis CAMP Cross-Reactor Committee 2019-2020, Dermatologists of the Central States, Dayton, OH, Probity Medical Research, Waterloo, Ontario, Canada CAMP Cross-Reactor Committee 2019-2020, Department of Dermatology, University of North Carolina, Chapel Hill CAMP Cross-Reactor Committee 2019-2020, Department of Dermatology, Weill Cornell Medicine, New York, NY CAMP Cross-Reactor Committee 2019-2020, Department of Dermatology, Northwestern University, Evanston, IL.
No abstract available in PubMed .
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Cross-reactivity
Allergic Drug Reactions
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Allergic Reactions
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

